Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.
2.

Prognostic role of the number of involved extraspinal organs in patients with metastatic spinal cord compression.

Rades D, Weber A, Karstens JH, Schild SE, Bartscht T.

Clin Neurol Neurosurg. 2014 Mar;118:12-5. doi: 10.1016/j.clineuro.2013.12.007. Epub 2013 Dec 27.

PMID:
24529222
3.

Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved.

Weber A, Bartscht T, Karstens JH, Schild SE, Rades D.

Anticancer Res. 2013 Oct;33(10):4505-7.

PMID:
24123022
4.

Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.

Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJ, Hoskin PJ, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Jun;188(6):472-6. doi: 10.1007/s00066-012-0086-3. Epub 2012 Feb 25.

PMID:
22361746
5.

Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.

Park SJ, Lee CS, Chung SS.

Spine J. 2016 Mar;16(3):322-8. doi: 10.1016/j.spinee.2015.11.005. Epub 2015 Nov 14.

PMID:
26586194
6.

A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer.

Rades D, Douglas S, Veninga T, Schild SE.

BMC Cancer. 2012 Jul 20;12:302. doi: 10.1186/1471-2407-12-302.

7.

Breast cancer patients with metastatic spinal cord compression. Number of extraspinal organs involved by metastases influences survival.

Weber A, Bartscht T, Karstens JH, Schild SE, Rades D.

Strahlenther Onkol. 2014 Mar;190(3):283-6. doi: 10.1007/s00066-013-0473-4. Epub 2013 Nov 23.

PMID:
24264465
8.

A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression.

Rades D, Weber A, Bartscht T, Bajrovic A, Karstens JH, Schild SE.

Strahlenther Onkol. 2014 Jul;190(7):667-70. doi: 10.1007/s00066-014-0616-2. Epub 2014 Feb 18.

PMID:
24535650
9.

Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.

Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE.

J Clin Oncol. 2005 May 20;23(15):3366-75.

PMID:
15908648
10.

Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer.

Lei M, Liu Y, Tang C, Yang S, Liu S, Zhou S.

BMC Cancer. 2015 Nov 5;15:853. doi: 10.1186/s12885-015-1852-2.

11.

Impact of Symptomatic Metastatic Spinal Cord Compression on Survival of Patients with Non-Small-Cell Lung Cancer.

da Silva GT, Bergmann A, Thuler LCS.

World Neurosurg. 2017 Dec;108:698-704. doi: 10.1016/j.wneu.2017.09.079. Epub 2017 Sep 22.

PMID:
28951180
12.

Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary.

Douglas S, Huttenlocher S, Bajrovic A, Rudat V, Schild SE, Rades D.

BMC Cancer. 2012 Jun 21;12:261. doi: 10.1186/1471-2407-12-261.

13.

Prognostic factors in a series of 504 breast cancer patients with metastatic spinal cord compression.

Rades D, Douglas S, Veninga T, Stalpers LJ, Bajrovic A, Rudat V, Schild SE.

Strahlenther Onkol. 2012 Apr;188(4):340-5. doi: 10.1007/s00066-011-0061-4. Epub 2012 Feb 23.

PMID:
22354333
14.

Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.

Rades D, Fehlauer F, Veninga T, Stalpers LJ, Basic H, Hoskin PJ, Rudat V, Karstens JH, Schild SE, Dunst J.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):532-7. Epub 2006 Nov 2.

PMID:
17084539
15.

Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.

Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE.

J Clin Oncol. 2006 Jul 20;24(21):3388-93.

PMID:
16849752
16.

A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer.

Rades D, Conde AJ, Garcia R, Cacicedo J, Segedin B, Perpar A, Schild SE.

Radiat Oncol. 2015 Aug 19;10:173. doi: 10.1186/s13014-015-0483-8.

17.

A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.

Rades D, Huttenlocher S, Veninga T, Bajrovic A, Bremer M, Rudat V, Schild SE.

Radiat Oncol. 2015 Apr 15;10:90. doi: 10.1186/s13014-015-0403-y.

18.

A score predicting posttreatment ambulatory status in patients irradiated for metastatic spinal cord compression.

Rades D, Rudat V, Veninga T, Stalpers LJ, Basic H, Karstens JH, Hoskin PJ, Schild SE.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):905-8. doi: 10.1016/j.ijrobp.2008.02.018. Epub 2008 Apr 23.

PMID:
18436390
19.

A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.

Rades D, Fehlauer F, Stalpers LJ, Wildfang I, Zschenker O, Schild SE, Schmoll HJ, Karstens JH, Alberti W.

Cancer. 2004 Dec 1;101(11):2687-92.

20.

Metastatic spinal cord compression: a validated survival score for elderly patients.

Rades D, Evers JN, Bajrovic A, Veninga T, Karstens JH, Schild SE.

Strahlenther Onkol. 2014 Oct;190(10):919-24. doi: 10.1007/s00066-014-0641-1. Epub 2014 Mar 22.

PMID:
24658606

Supplemental Content

Support Center